Trailing-twelve-month (TTM) revenue is $1.01 Billion with a year-over-year growth of +9.82%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $258,518,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $242,127,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-23 |
| Q1 FY2026Period ended 2026-03-31 | $247,631,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $261,246,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $1,009,522,000 |
Current P/S: $2,362,896,720 market capitalization ÷ $1,009,522,000 TTM revenue = 2.34x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $261.25M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:47:46.817Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $32M | $28M | $100M | $146M | $172M | $184M |
| Service | $107M | $116M | $447M | $648M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Not Connected Country | $102M | $111M | $506M | $751M | $855M | $926M |
| Other | $7M | $14M | $20M | $23M |
$1.01B
$1.01 Billion
+9.82%
vs. $919.25M a year ago (TTM)
+118.32%
5 Year compound annual growth rate
1 Year
+9.82%
3 Year
+12.23%
5 Year
+118.32%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $961.00M | +$65.98M | +7.37% |
| 2024 | $895.02M | +$100.97M | +12.72% |
| 2023 | $794.04M | +$247.79M | +45.36% |
| 2022 | $546.26M | +$402.23M | +279.26% |
| 2021 | $144.03M | +$23.11M | +19.11% |
| 2020 |
TTM Growth
+9.82%
3-Year CAGR
+12.23%
5-Year CAGR
+118.32%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T20:47:46.817Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $777M |
| $19M |
| UNITED STATES | $12M | $19M | $20M | $20M | $18M | $16M |
|---|
| $120.92M |
| ($441.31M) |
| (78.49%) |
| 2019 | $562.23M | +$21.45M | +3.97% |
| 2018 | $540.78M | +$34.09M | +6.73% |
| 2017 | $506.69M | +$30.40M | +6.38% |
